[PECULIARITIES OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN WITH NEUROLOGICAL PATHOLOGY]

O Zubarenko1, G Kopiyka1, T Kravchenko1

  • 1Odessa National Medical University, Odessa, Ukraine.

Georgian Medical News
|July 21, 2017
PubMed

Insights

Children with infantile cerebral palsy (ICP) face a higher risk of severe community-acquired pneumonia with distinct clinical features. Early recognition of ICP

Area of Science:

  • Pediatrics
  • Neurology
  • Pulmonology

Background:

  • Neurological disorders significantly impact pediatric pneumonia course and complications.
  • Infantile cerebral palsy (ICP) presents unique challenges in managing respiratory infections.

Purpose of the Study:

  • To identify clinical and paraclinical features of community-acquired pneumonia (CAP) in young children with ICP.
  • To compare CAP presentation in children with and without ICP.

Main Methods:

  • Observational study comparing 37 children with CAP and ICP to 30 children with CAP but no neurological pathology.
  • Analysis of clinical symptoms, physical findings, laboratory data, and treatment outcomes.

Main Results:

  • Children with ICP showed rapid symptom progression and increased severity of CAP.
  • Less frequent cough, localized physical findings, and leukocytosis with neutrophil shift were observed in children with ICP.
  • Bronchial obstruction at onset, lower lobe inflammation, and contralateral lung involvement were common in the ICP group.
  • Children with ICP required longer hospitalization and antibiotic treatment.

Conclusions:

  • ICP is a risk factor for developing severe respiratory pathology, including CAP.
  • CAP in children with ICP has distinct clinical and paraclinical features requiring tailored management.
  • Preventive strategies for pneumonia in children with ICP are crucial at the primary care level.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
966
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.4K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
868
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377